Massive immune cell study aims to unlock cancer secrets

NCT ID NCT03958240

First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 24 times

Summary

This study will enroll 1100 people with various cancers, including head and neck, ovarian, cervical, lung, and brain cancers. Researchers will collect tumor and blood samples to measure specific immune cells (T cells) and their activity. The goal is to better understand how the immune system reacts to different tumors, which may help improve future treatments. Participants will be followed for up to 5 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hopital Larrey

    RECRUITING

    Toulouse, 31059, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hopital Rangueil

    RECRUITING

    Toulouse, 31059, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut Universitaire du Cancer Toulouse - Oncopole

    RECRUITING

    Toulouse, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.